LDR | |
01335nam a22003371i 4500 |
001 |
|
000030246 |
003 |
|
MiAaHDL |
005 |
|
20221205000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
880715s1980 dcua b 10100 eng |
010 |
⊔ |
⊔ |
‡a79024958
|
020 |
⊔ |
⊔ |
‡a0841205361
|
035 |
⊔ |
⊔ |
‡a(MiU)990000302460106381
|
035 |
⊔ |
⊔ |
‡asdr-miu.990000302460106381
|
035 |
⊔ |
⊔ |
‡z(MiU)MIU01000000000000000030246-goog
|
035 |
⊔ |
⊔ |
‡a(OCoLC)5750860
|
035 |
⊔ |
⊔ |
‡a(CaOTULAS)159850636
|
035 |
⊔ |
⊔ |
‡a(RLIN)MIUG16418913-B
|
035 |
⊔ |
⊔ |
‡z(MiU)Aleph000030246
|
040 |
⊔ |
⊔ |
‡dMiU
|
050 |
0 |
⊔ |
‡aRM388
‡b.D78
|
082 |
⊔ |
⊔ |
‡a615/.72
|
245 |
0 |
0 |
‡aDrugs affecting the respiratory system :
‡bbased on a symposium sponsored by the Division of Medicinal Chemistry, at the 175th meeting of the American Chemical Society, Anaheim, California, March 13-16, 1978 /
‡cDavis L. Temple, Jr., editor.
|
260 |
⊔ |
⊔ |
‡aWashington, D.C. :
‡bThe Society,
‡c1980.
|
300 |
⊔ |
⊔ |
‡ax, 396 p. :
‡bill. ;
‡c24 cm.
|
490 |
0 |
⊔ |
‡aACS symposium series ; 118
|
504 |
⊔ |
⊔ |
‡aIncludes bibliographical references and index.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
0 |
‡aDrugs
‡xStructure-activity relationships
‡xCongresses.
|
650 |
⊔ |
0 |
‡aRespiratory agents
‡xCongresses.
|
700 |
1 |
⊔ |
‡aTemple, Davis L.,
‡d1943-
|
710 |
2 |
⊔ |
‡aAmerican Chemical Society.
‡bDivision of Medicinal Chemistry.
|
899 |
⊔ |
⊔ |
‡a39015003224550
|
CID |
⊔ |
⊔ |
‡a000030246
|
DAT |
0 |
⊔ |
‡a19880715000000.0
‡b20221205000000.0
|
DAT |
1 |
⊔ |
‡a20221207060734.0
‡b2023-06-23T17:34:02Z
|
CAT |
⊔ |
⊔ |
‡aSDR-MIU
‡cmiu
‡dALMA
‡lprepare.pl-004-008
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-miu.990000302460106381
‡aMiU
‡bSDR
‡cMIU
‡f000030246
‡pmdp.39015003224550
‡sMIU
‡1990000302460106381
|
974 |
⊔ |
⊔ |
‡bMIU
‡cMIU
‡d20230623
‡sgoogle
‡umdp.39015003224550
‡y1980
‡ric
‡qbib
‡tUS bib date1 >= 1929
|